JP2023544173A5 - - Google Patents
Info
- Publication number
- JP2023544173A5 JP2023544173A5 JP2023520080A JP2023520080A JP2023544173A5 JP 2023544173 A5 JP2023544173 A5 JP 2023544173A5 JP 2023520080 A JP2023520080 A JP 2023520080A JP 2023520080 A JP2023520080 A JP 2023520080A JP 2023544173 A5 JP2023544173 A5 JP 2023544173A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- salt
- fibrosis
- disease
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063086728P | 2020-10-02 | 2020-10-02 | |
| US63/086,728 | 2020-10-02 | ||
| PCT/US2021/052898 WO2022072648A1 (en) | 2020-10-02 | 2021-09-30 | Imidazopiperazine inhibitors of transcription activating proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544173A JP2023544173A (ja) | 2023-10-20 |
| JP2023544173A5 true JP2023544173A5 (cg-RX-API-DMAC7.html) | 2024-10-07 |
| JP7865951B2 JP7865951B2 (ja) | 2026-05-26 |
Family
ID=80950902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520080A Active JP7865951B2 (ja) | 2020-10-02 | 2021-09-30 | 転写活性化タンパク質のイミダゾピペラジン阻害剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12559497B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4221709B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7865951B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230080441A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116261454A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021355480B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3193745A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK4221709T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3068299T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301707A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023003785A (cg-RX-API-DMAC7.html) |
| PL (1) | PL4221709T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT4221709T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022072648A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7777131B2 (ja) | 2020-10-02 | 2025-11-27 | ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム | 転写活性化タンパク質のイミダゾピペラジン阻害剤 |
| KR20230080441A (ko) | 2020-10-02 | 2023-06-07 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 전사 활성화 단백질의 이미다조피페라진 억제제 |
| AU2024331409A1 (en) * | 2023-08-30 | 2026-03-12 | Oncopia Therapeutics, Inc. D/B/A Sk Life Science Labs | Compounds and compositions as cbp/p300 degraders and uses thereof |
| WO2026128761A1 (en) | 2024-12-11 | 2026-06-18 | Nexo Therapeutics, Inc. | Covalent p300 inhibitor compounds |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2270143T3 (es) | 2002-08-07 | 2007-04-01 | Novartis Ag | Compuestos organicos como agentes para el tratamiento de condiciones mediadas por aldosterona. |
| US20070004736A1 (en) | 2002-11-22 | 2007-01-04 | Keiji Kubo | Imidazole derivative, process for producing the same, and use |
| WO2007139992A2 (en) | 2006-05-26 | 2007-12-06 | Novartis Ag | ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS |
| US7943617B2 (en) | 2006-11-27 | 2011-05-17 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as kinase inhibitors |
| AU2007337659A1 (en) * | 2006-12-22 | 2008-07-03 | Actelion Pharmaceuticals Ltd. | 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives |
| US8859538B2 (en) | 2007-06-21 | 2014-10-14 | Cara Therapeutics, Inc. | Uses of substituted imidazoheterocycles |
| EA201000046A1 (ru) | 2007-06-21 | 2011-02-28 | Кара Терапеутикс, Инк. | Замещенные имидазогетероциклы |
| CN101417999A (zh) | 2007-10-25 | 2009-04-29 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
| CN101468988A (zh) | 2007-12-26 | 2009-07-01 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
| KR20110036069A (ko) | 2008-06-25 | 2011-04-06 | 액테리온 파마슈티칼 리미티드 | 5,6,7,8-테트라히드로-이미다조[1,5-a]피라진 화합물 |
| WO2011092120A1 (en) | 2010-01-29 | 2011-08-04 | Nerviano Medical Sciences S.R.L. | 6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators |
| CN102372716A (zh) | 2010-08-09 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
| WO2013050446A1 (en) | 2011-10-07 | 2013-04-11 | Nerviano Medical Sciences S.R.L. | SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS |
| CN103087067A (zh) | 2012-08-02 | 2013-05-08 | 盛世泰科生物医药技术(苏州)有限公司 | 作为二肽基酶抑制剂的化合物及其组合物,以及它们的用途 |
| WO2014062548A1 (en) | 2012-10-18 | 2014-04-24 | Bristol-Myers Squibb Company | Tetrahydroimdidazopyrazine derivatives as cgrp receptor antagonists |
| US9371282B2 (en) * | 2013-05-17 | 2016-06-21 | Centrexion Therapeutics Corporation | Somatostatin receptor subtype 4 (SSTR4) agonists |
| CA2915163A1 (en) | 2013-06-12 | 2014-12-18 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| CN106456628A (zh) * | 2014-03-19 | 2017-02-22 | 无限药品股份有限公司 | 用于治疗PI3K‑γ介导的障碍的杂环化合物 |
| CN107108512B (zh) | 2014-10-10 | 2021-05-04 | 基因泰克公司 | 治疗性化合物及其用途 |
| EP3632915A1 (en) * | 2014-11-27 | 2020-04-08 | Genentech, Inc. | 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors |
| MA41338B1 (fr) | 2015-01-16 | 2019-07-31 | Hoffmann La Roche | Composés de pyrazine pour le traitement de maladies infectieuses |
| GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| AU2017252276A1 (en) | 2016-04-18 | 2018-11-15 | Celgene Quanticel Research, Inc. | Therapeutic compounds |
| MA45146A (fr) | 2016-05-24 | 2021-03-24 | Constellation Pharmaceuticals Inc | Dérivés de pyrazolopyridine pour le traitement du cancer |
| WO2017205536A2 (en) | 2016-05-24 | 2017-11-30 | Genentech, Inc. | Therapeutic compounds and uses thereof |
| CA3095367A1 (en) | 2018-03-29 | 2019-10-03 | Board Of Regents, The University Of Texas System | Imidazopiperazine inhibitors of transcription activating proteins |
| WO2019195846A1 (en) | 2018-04-06 | 2019-10-10 | Board Of Regents, The University Of Texas System | Imidazopiperazinone inhibitors of transcription activating proteins |
| JP7777131B2 (ja) | 2020-10-02 | 2025-11-27 | ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム | 転写活性化タンパク質のイミダゾピペラジン阻害剤 |
| KR20230080441A (ko) | 2020-10-02 | 2023-06-07 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 전사 활성화 단백질의 이미다조피페라진 억제제 |
-
2021
- 2021-09-30 KR KR1020237014382A patent/KR20230080441A/ko active Pending
- 2021-09-30 CA CA3193745A patent/CA3193745A1/en active Pending
- 2021-09-30 DK DK21876484.3T patent/DK4221709T3/da active
- 2021-09-30 CN CN202180068106.3A patent/CN116261454A/zh active Pending
- 2021-09-30 PT PT218764843T patent/PT4221709T/pt unknown
- 2021-09-30 EP EP21876484.3A patent/EP4221709B1/en active Active
- 2021-09-30 PL PL21876484.3T patent/PL4221709T3/pl unknown
- 2021-09-30 IL IL301707A patent/IL301707A/en unknown
- 2021-09-30 JP JP2023520080A patent/JP7865951B2/ja active Active
- 2021-09-30 AU AU2021355480A patent/AU2021355480B2/en active Active
- 2021-09-30 ES ES21876484T patent/ES3068299T3/es active Active
- 2021-09-30 MX MX2023003785A patent/MX2023003785A/es unknown
- 2021-09-30 WO PCT/US2021/052898 patent/WO2022072648A1/en not_active Ceased
-
2023
- 2023-03-13 US US18/182,620 patent/US12559497B2/en active Active
-
2026
- 2026-01-09 US US19/444,434 patent/US20260132138A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018515490A5 (cg-RX-API-DMAC7.html) | ||
| RU2020131507A (ru) | Имидазопиперазиновые ингибиторы белков-активаторов транскрипции | |
| JP5269762B2 (ja) | Mek阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド | |
| CN115626935B (zh) | 用作prmt5抑制剂的单环和双环系统取代的卡巴核苷类似物 | |
| JP2019516759A5 (cg-RX-API-DMAC7.html) | ||
| CN111770914B (zh) | 作为神经激肽-1受体拮抗剂的化合物及其用途 | |
| KR20210018291A (ko) | 항암 핵 호르몬 수용체-표적화 화합물 | |
| JP2023544732A5 (cg-RX-API-DMAC7.html) | ||
| JP2020517637A (ja) | Tnf活性のモジュレーターとしての縮合五環式イミダゾール誘導体 | |
| JP6019126B2 (ja) | 有機ニトロチオエーテル化合物およびその医療用途 | |
| JP2019513743A (ja) | インドールアミン 2,3−ジオキシゲナーゼ阻害剤、その製造方法及び応用 | |
| JP2017510641A5 (cg-RX-API-DMAC7.html) | ||
| JP6842474B2 (ja) | ステロイド系化合物、当該化合物を含む組成物及びその使用 | |
| JP2021505641A (ja) | PPAR−γ調節薬としての新規なベンズアミド誘導体 | |
| JP2018501287A5 (cg-RX-API-DMAC7.html) | ||
| IL298966A (en) | Bicyclic compound and application thereof | |
| JP7691974B2 (ja) | アセチル補酵素aシンテターゼ短鎖2(acss2)の小分子阻害剤 | |
| CN111303133A (zh) | 降解ezh2蛋白的小分子化合物 | |
| WO2025209490A1 (en) | Macrocyclic compound, preparation methods and medicinal uses thereof | |
| JP2023544173A (ja) | 転写活性化タンパク質のイミダゾピペラジン阻害剤 | |
| US20210196724A1 (en) | Biaryl compositions and methods for modulating a kinase cascade | |
| TW200932217A (en) | Substituted hydantoins | |
| TW201245183A (en) | Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid | |
| CN106432209A (zh) | Lumacaftor的新晶型及其制备方法 | |
| JP2023544732A (ja) | 転写活性化タンパク質のイミダゾピペラジン阻害剤 |